Literature DB >> 7667376

Morphine-induced modification of quinine palatability: effects of multiple morphine-quinine trials.

S N Clarke1, L A Parker.   

Abstract

Morphine pretreatment attenuates aversive taste reactions elicited by quinine solution when assessed by the taste reactivity test. To determine whether this effect changes across trials, rats were administered morphine (2 mg/kg, subcutaneously) 30 min before a 5-min intraoral infusion of quinine solution (0.05%) on each of eight trials. Neither tolerance nor sensitization developed to morphine-induced attenuation of quinine aversiveness; morphine suppressed quinine-elicited aversive reactions on each trial. In addition, when tested in the absence of morphine, rats displayed a reduced aversion to quinine, suggesting that quinine became conditionally less aversive following previous pairings with morphine.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7667376     DOI: 10.1016/0091-3057(95)00042-u

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  5 in total

Review 1.  Preference or fat? Revisiting opioid effects on food intake.

Authors:  Sharif A Taha
Journal:  Physiol Behav       Date:  2010-03-04

Review 2.  Feeding-modulatory effects of mu-opioids in the medial prefrontal cortex: a review of recent findings and comparison to opioid actions in the nucleus accumbens.

Authors:  Ryan A Selleck; Brian A Baldo
Journal:  Psychopharmacology (Berl)       Date:  2017-01-04       Impact factor: 4.530

3.  Opioid mechanisms that mediate the palatability of and appetite for salt in sodium replete and deficient states.

Authors:  Elisa S Na; Michael J Morris; Alan Kim Johnson
Journal:  Physiol Behav       Date:  2012-02-02

Review 4.  Conditioned taste aversion, drugs of abuse and palatability.

Authors:  Jian-You Lin; Joe Arthurs; Steve Reilly
Journal:  Neurosci Biobehav Rev       Date:  2014-05-09       Impact factor: 8.989

5.  Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer.

Authors:  Wanting Shao; Christina Kuhn; Doris Mayr; Nina Ditsch; Magdalena Kailuwait; Verena Wolf; Nadia Harbeck; Sven Mahner; Udo Jeschke; Vincent Cavaillès; Sophie Sixou
Journal:  J Cancer Res Clin Oncol       Date:  2021-06-03       Impact factor: 4.553

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.